Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Novo Nordisk A/S
Recent news which mentions Novo Nordisk A/S
< Previous
1
2
3
4
5
6
Next >
Weight-loss drug Wegovy could get expanded FDA approval within six months, Novo Nordisk says
November 02, 2023
Tags
Pharmaceuticals
Business
Novo Nordisk A/S
From
CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
November 02, 2023
Tags
Weight management
Pharmaceuticals
Business
From
CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
October 31, 2023
Tags
Novo Nordisk A/S
Pfizer Inc
Biotech and Pharmaceuticals
From
CNBC.com News
As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data
October 24, 2023
Tags
Weight management
Abbott Laboratories
Breaking News: Technology
From
CNBC.com News
CNBC Daily Open: Oil deals ahead of Big Tech earnings
October 24, 2023
Tags
Alphabet Inc
Hess Corp
Daily Open
From
CNBC.com News
CNBC Daily Open: Oil deals and awaiting tech earnings
October 23, 2023
Tags
Hess Corp
Daily Open
Alphabet Inc
From
CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
October 23, 2023
Tags
Health & Science
Novo Nordisk A/S
Investing
From
CNBC.com News
Sanofi to offer insulin product for $35 to all Americans through GoodRx
October 19, 2023
Tags
Eli Lilly and Co
Health care industry
CVS Health Corp
From
CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
October 14, 2023
Tags
Investing
Breaking News: Investing
Fast Money
From
CNBC.com News
Novo Nordisk hikes outlook on soaring demand for Wegovy, Ozempic
October 13, 2023
Tags
US: News
Companies
Biotechnology
From
CNBC.com News
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
October 11, 2023
Tickers
BIRK
EVS
MSFT
NVO
Tags
Tempest Therapeutics
Market News
Birkenstock
From
Benzinga
How is the rise of GLP-1 weight loss drugs affecting market action? Jim Cramer explains
October 11, 2023
Tags
Investment Strategy
Walmart Inc
Business
From
CNBC.com News
Stocks making the biggest moves midday: Novo Nordisk, DaVita, Exxon Mobil, Amgen and more
October 11, 2023
Tags
Take/Two Interactive Software Inc
Fresenius Medical Care AG & Co KGaA
Walgreens Boots Alliance Inc
From
CNBC.com News
Stocks making the biggest moves premarket: Plug Power, Exxon Mobil, Pioneer, Novo Nordisk and more
October 11, 2023
Tags
Novo Nordisk A/S
Pioneer Natural Resources Co
Market Insider
From
CNBC.com News
LVMH shares fall to 2023 low as growth slows, pulling luxury sector down
October 11, 2023
Tags
Novo Nordisk A/S
LVMH Moet Hennessy Louis Vuitton SE
Europe Markets
From
CNBC.com News
How Ozempic and Wegovy turned Novo Nordisk into a $400 billion company
October 10, 2023
Tickers
CEO
Tags
Diabetes
Health care industry
Eli Lilly and Co
From
CNBC.com News
Here are 20 stocks I'm watching Tuesday, including Lilly, AMD and Goldman Sachs
October 10, 2023
Tags
Rivian Automotive Inc
Walgreens Boots Alliance Inc
NVIDIA Corp
From
CNBC.com News
Weight loss drugs may be linked to stomach paralysis, other rare but severe issues, study says
October 05, 2023
Tags
US: News
Companies
Biotechnology
From
CNBC.com News
Here are 18 stocks I am watching in the market, including Clorox, Rivian and Airbnb
October 05, 2023
Tags
Novo Nordisk A/S
Investment strategy
SoFi Technologies Inc
From
CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
October 02, 2023
Tags
Business
Pharmaceuticals
Breaking news
From
CNBC.com News
Big Food vs. Big Pharma: Companies bet on snacking just as weight loss drugs boom
October 01, 2023
Tags
Retail
Kellogg Co
J M Smucker Co
From
CNBC.com News
Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
September 29, 2023
Tags
Novo Nordisk A/S
Biotech and Pharmaceuticals
Pfizer Inc
From
CNBC.com News
Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million
September 29, 2023
Tags
Health & Science
Business News
Companies
From
CNBC.com News
Ozempic, Wegovy drug prescriptions hit 9 million, surge 300% in under three years
September 27, 2023
Tags
Weight management
Business
Pharmaceuticals
From
CNBC.com News
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
September 19, 2023
Tags
Lawsuits
Breaking news
Pharmaceuticals
From
CNBC.com News
Here's why Jim Cramer likes J.M. Smucker's plan to buy the maker of Twinkies
September 11, 2023
Tags
CNBC Investing Club
Mergers
Eli Lilly and Co
From
CNBC.com News
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
September 10, 2023
Tags
Companies
US: News
Nicotine addiction
From
CNBC.com News
Big pharma's blockbuster obesity drug battle is just getting started, and it's headed for $100 billion
September 09, 2023
Tags
Drugs
Pfizer Inc
Novo Nordisk A/S
From
CNBC.com News
Blockbuster weight loss drugs Wegovy and Ozempic are being tested to treat addiction and dementia
September 07, 2023
Tags
Pharmaceuticals
Eli Lilly and Co
Science
From
CNBC.com News
Stocks making the biggest moves premarket: Enbridge, Roku, Gitlab and more
September 06, 2023
Tags
Earnings
Asana Inc
Toast Inc
From
CNBC.com News
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.